NCT04778943 is a clinical trial of Surgery(OLIF and MIS-TLIF) in Lumbar Spinal Stenosis, sponsored by Tang-Du Hospital.

Who is sponsoring NCT04778943?

NCT04778943 is sponsored by Tang-Du Hospital.

What drugs are being tested in NCT04778943?

Interventions in NCT04778943: Surgery(OLIF and MIS-TLIF).

What condition does NCT04778943 study?

NCT04778943 studies Lumbar Spinal Stenosis.

Is NCT04778943 still recruiting?

NCT04778943 is currently status unknown. Last updated 3 March 2021.

Last reviewed 2021-03-03 · How we verify

NCT04778943

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion

Status unknown Last updated 3 March 2021

What this trial tests

trial testing Surgery(OLIF and MIS-TLIF) in Lumbar Spinal Stenosis in 130 participants. Status unknown.

Timeline

28 February 2021

Primary endpoint
25 March 2021

29 March 2021

Quick facts

Lead sponsor	Tang-Du Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	130
Start date	28 February 2021
Primary completion	25 March 2021
Estimated completion	29 March 2021

Drugs / interventions tested

Surgery(OLIF and MIS-TLIF)

Conditions studied

Lumbar Spinal Stenosis — all drugs for Lumbar Spinal Stenosis →

Sponsor

Tang-Du Hospital

Who can join

Adults 50 to 80, any sex, with Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will retrospectively study lumbar spinal stenosis patients who underwent OLIF or MIS-TLIF with percutaneous pedicle screw fixation between January 2016 and December 2019.The investigators will measure estimated blood loss, operative time, hospital stay, cost, reoperation, and complication incidence, visual analogue scale (VAS), Oswestry Disability Index (ODI), Japanese Orthopaedic Association (JOA), and Short Form-36 (SF-36) scores, discal and foraminal height, lumbar lordotic angle, and fusion status.The investigators will conduct to evaluate postoperative improvements, complications, and reoperation rates between patients with lumbar spinal stenosis (LSS) undergoing oblique lateral interbody fusion (OLIF) or minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lumbar Spinal Stenosis

Currently open trials in the same condition.

NCT07489001 — Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery · recruiting
NCT07233798 — Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis · recruiting
NCT07281625 — Decompressive Laminectomy Versus Laminectomy With Transpedicular Fixation in Lumbar Spinal Stenosis · EARLY_PHASE1 · recruiting
NCT07001982 — Lumbar Spinal Stenosis and Central Sensitization · recruiting
NCT06959355 — Frailty and Associated Factors in Lumbar Spinal Stenosis · recruiting

Other Tang-Du Hospital trials

Trials by the same sponsor.

NCT07528235 — An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intraven · Phase 1 · not yet recruiting
NCT07516522 — Intra-arterial Methylprednisolone After Endovascular Thrombectomy · Phase 2 · recruiting
NCT07354061 — Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC) · Phase 1, PHASE2 · recruiting
NCT07327736 — Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT · NA · not yet recruiting
NCT07452601 — Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04778943 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tang-Du Hospital
Last refreshed: 3 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04778943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing